Jpmorgan Chase & CO Acutus Medical, Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.49 - $1.3 $4,392 - $11,654	-8,965 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$1.39 - $3.92 $213,071 - $600,892	-153,289 Reduced 94.47%	8,965 $12,000
Q4 2021 Feb 10, 2022	BUY	$3.1 - $8.97 $480,289 - $1.39 Million	154,932 Added 2115.98%	162,254 $553,000
Q3 2021 Nov 12, 2021	BUY	$8.35 - $16.99 $61,138 - $124,400	7,322 New	7,322 $65,000

Ticker AFIB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,370,300
Market Cap $1.42M
Description
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conv...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.